ArticleAmerican journal of respiratory and critical care medicine2024

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.

Ratko Djukanović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.